State TX
Clinical Trials in Texas
Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Texas
NCT04485559 Phase 1
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients Wi...
Condition
Recurrent World Health Organization (WHO) Grade II Glioma
Enrollment
50 pts
Location
United States
Sponsor
University of California, San
NCT04098146 N/A
Recruiting
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reco...
Condition
Mandibular Reconstruction
Enrollment
300 pts
Location
United States, Germany, Japan
Sponsor
AO Innovation Translation Cent
NCT05474846 Phase 2, Phase 3
Recruiting
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced...
Condition
Sleep
Enrollment
188 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06705842 Phase 4
Recruiting
APPI-Cost Trial for Perforated Appendicitis
Condition
Perforated Appendicitis
Enrollment
346 pts
Location
United States
Sponsor
The University of Texas Health
NCT04510597 Phase 3
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Wi...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
364 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07415824 N/A
Recruiting
Multiple Sclerosis Implementation Network (Registry)
Condition
Multiple Sclerosis
Enrollment
2,000 pts
Location
United States
Sponsor
The University of Texas Health
NCT06894979 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy f...
Condition
Childhood Astrocytoma
Enrollment
54 pts
Location
United States
Sponsor
Children's Oncology Group
NCT07215559 Phase 2
Recruiting
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Comb...
Condition
Obesity
Enrollment
200 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT06636383 N/A
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Condition
Glycogen Storage Disease Type Ia
Enrollment
140 pts
Location
United States, Brazil, Canada
Sponsor
Ultragenyx Pharmaceutical Inc
NCT03982160 Phase 4
Recruiting
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
Condition
Chronic Kidney Disease
Enrollment
15 pts
Location
United States
Sponsor
The University of Texas at Arl
NCT05312879 Phase 2, Phase 3
Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL...
Condition
Proteinuric Kidney Disease
Enrollment
466 pts
Location
United States, Belgium, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05180773 Phase 4
Recruiting
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Condition
Peripartum Cardiomyopathy, Postpartum
Enrollment
250 pts
Location
United States
Sponsor
Dennis M. McNamara, MD, MS
NCT04015141 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunct...
Condition
Pediatric Epileptic Syndrome
Enrollment
100 pts
Location
United States, Belgium, Czechia
Sponsor
Eisai Inc.
NCT06006273 Phase 1
Recruiting
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in ...
Condition
Refractory Solid Tumors
Enrollment
48 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06668805 Phase 2
Recruiting
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Hom...
Condition
Short Stature Homeobox- Containing Gene SHOX Deficiency
Enrollment
54 pts
Location
United States, Australia, France
Sponsor
BioMarin Pharmaceutical
NCT05986292 Phase 2
Recruiting
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices ...
Condition
Osteoarthritis, Knee
Enrollment
10,000 pts
Location
United States, Puerto Rico
Sponsor
Eli Lilly and Company
NCT05640999 Phase 2
Recruiting
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial C...
Condition
Endometrial Cancer
Enrollment
393 pts
Location
United States, Australia, Canada
Sponsor
Canadian Cancer Trials Group
NCT05691244 Phase 3
Recruiting
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Is...
Condition
Acute Ischemic Stroke
Enrollment
514 pts
Location
United States, Germany, Spain
Sponsor
Pharmazz, Inc.
NCT06003348 Phase 4
Recruiting
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
Condition
Calcium Phosphate Kidney Stones
Enrollment
25 pts
Location
United States
Sponsor
University of Texas Southweste
NCT06842355 Phase 2
Recruiting
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Condition
Achondroplasia
Enrollment
92 pts
Location
United States, Australia, Canada
Sponsor
Tyra Biosciences, Inc
NCT04692493 Phase 3
Recruiting
RA-PRO PRAGMATIC TRIAL
Condition
Rheumatoid Arthritis
Enrollment
924 pts
Location
United States, Canada
Sponsor
University of Alabama at Birmi
NCT07106593 N/A
Recruiting
Treatment for PTSD and Tinnitus
Condition
PTSD - Post Traumatic Stress Disorder
Enrollment
160 pts
Location
United States
Sponsor
The University of Texas Health
NCT07205887 Phase 2
Recruiting
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular...
Condition
Neovascular Age-Related Macular Degeneration (NVAMD)
Enrollment
160 pts
Location
United States
Sponsor
EyeBiotech Ltd.
NCT06708949 Phase 2
Recruiting
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivoluma...
Condition
Renal Cell Carcinoma, Clear Cell
Enrollment
15 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06114199 N/A
Recruiting
Enhancing the Effectiveness of Home-delivery Based Produce Prescription Program ...
Condition
Nutritional Deficiency in Pregnancy
Enrollment
200 pts
Location
United States
Sponsor
The University of Texas Health